New age for progressive multiple sclerosis.
作者信息
Imitola Jaime
机构信息
Laboratory for Neural Stem Cells and Functional Neurogenetics, Progressive Multiple Sclerosis Clinic and Translational Research Program, Division of Neuroimmunology and Multiple Sclerosis, Department of Neurology, The Ohio State University Neurological Institute, The Ohio State University, Columbus, OH 43221
出版信息
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8646-8648. doi: 10.1073/pnas.1903796116. Epub 2019 Apr 19.
Abstract
摘要
相似文献
1
New age for progressive multiple sclerosis.
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8646-8648. doi: 10.1073/pnas.1903796116. Epub 2019 Apr 19.
2
Demyelination versus remyelination in progressive multiple sclerosis.
Brain. 2010 Oct;133(10):2983-98. doi: 10.1093/brain/awq250. Epub 2010 Sep 20.
3
Premature cellular ageing limits remyelination in progressive MS.
Nat Rev Neurol. 2019 Jun;15(6):309. doi: 10.1038/s41582-019-0187-z.
4
Therapeutic opportunities for targeting cellular senescence in progressive multiple sclerosis.
Curr Opin Pharmacol. 2022 Apr;63:102184. doi: 10.1016/j.coph.2022.102184. Epub 2022 Feb 18.
5
Remyelination in multiple sclerosis.
Mult Scler. 1997 Apr;3(2):133-6. doi: 10.1177/135245859700300213.
6
Inflammation stimulates remyelination in areas of chronic demyelination.
Brain. 2005 Mar;128(Pt 3):528-39. doi: 10.1093/brain/awh417. Epub 2005 Feb 7.
7
Multiple Sclerosis: Basic and Clinical.
Adv Neurobiol. 2017;15:211-252. doi: 10.1007/978-3-319-57193-5_8.
8
Remyelination strategies in multiple sclerosis: a critical reflection.
Expert Rev Neurother. 2016;16(1):1-3. doi: 10.1586/14737175.2016.1116387. Epub 2015 Nov 30.
9
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
N Engl J Med. 2002 Jan 17;346(3):165-73. doi: 10.1056/NEJMoa010994.
10
Adaptive human immunity drives remyelination in a mouse model of demyelination.
Brain. 2017 Apr 1;140(4):967-980. doi: 10.1093/brain/awx008.
引用本文的文献
1
The Core of Gut Life: Profile in Patients with Relapsing-Remitting Multiple Sclerosis.
Life (Basel). 2021 Jan 14;11(1):55. doi: 10.3390/life11010055.
2
Primary progressive multiple sclerosis in a Russian cohort: relationship with gut bacterial diversity.
BMC Microbiol. 2019 Dec 30;19(1):309. doi: 10.1186/s12866-019-1685-2.
本文引用的文献
1
Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis.
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9030-9039. doi: 10.1073/pnas.1818348116. Epub 2019 Mar 25.
2
Altered human oligodendrocyte heterogeneity in multiple sclerosis.
Nature. 2019 Feb;566(7745):543-547. doi: 10.1038/s41586-019-0903-2. Epub 2019 Jan 23.
3
Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures.
Nat Neurosci. 2019 Mar;22(3):484-491. doi: 10.1038/s41593-018-0316-9. Epub 2019 Jan 28.
4
Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation.
Nat Commun. 2019 Jan 15;10(1):217. doi: 10.1038/s41467-018-08140-7.
5
Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis.
Nat Commun. 2018 Dec 17;9(1):5337. doi: 10.1038/s41467-018-07785-8.
6
Multiple sclerosis risk factors contribute to onset heterogeneity.
Mult Scler Relat Disord. 2019 Feb;28:11-16. doi: 10.1016/j.msard.2018.12.007. Epub 2018 Dec 4.
7
The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells.
Brain. 2018 Jul 1;141(7):2066-2082. doi: 10.1093/brain/awy151.
8
A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants.
Sci Transl Med. 2017 Dec 20;9(421). doi: 10.1126/scitranslmed.aai7635.
9
iPhemap: an atlas of phenotype to genotype relationships of human iPSC models of neurological diseases.
EMBO Mol Med. 2017 Dec;9(12):1742-1762. doi: 10.15252/emmm.201708191.
10
Vitamin D and multiple sclerosis: An update.
Mult Scler Relat Disord. 2017 May;14:35-45. doi: 10.1016/j.msard.2017.03.014. Epub 2017 Mar 29.
Zotero 插件